Translating Genome Engineering to Survival

Jakub Tolar

doi:10.1016/B978-0-12-800563-7.00001-4

Translating Genome Engineering to Survival

Jakub Tolar

Research output: Chapter in Book/Report/Conference proceeding › Chapter

1 Scopus citations

Abstract

An incredible number and diversity of genetic diseases afflict humans. Despite the best efforts of medicine to reduce the suffering these diseases cause, curing them has remained out of reach. We are now at the point in time where genome engineering is stunningly close to being able to repair a genetic error and restore gene function. This volume outlines important examples of the tools and practice of gene therapy today. This incredible capability remains at the edges of existing science in new and predictably controversial territory. Similar to any other medical intervention, gene therapy is not devoid of risks. Understanding and controlling these risks while moving these technologies into the practice of medicine remain the goals for translational research. The chapters you are about to read demonstrate that fluency across basic science and clinical practice is possible and necessary for the robust application of gene therapy to improved survival.

Original language	English (US)
Title of host publication	Translating Gene Therapy to the Clinic
Subtitle of host publication	Techniques and Approaches
Publisher	Elsevier Inc.
Pages	1-10
Number of pages	10
ISBN (Electronic)	9780128005644
ISBN (Print)	9780128005637
DOIs	https://doi.org/10.1016/B978-0-12-800563-7.00001-4
State	Published - 2015

Bibliographical note

Funding Information:
The author apologizes to the authors whose work could not be quoted because of space constraints and thanks Nancy Griggs Morgan for editorial assistance. J.T. is supported by grants from the National Institutes of Health (R01 AR063070 and R01 AR059947), the Department of Defense (USAMRAA/DOD Department of the Army W81XWH-12-1-0609 and USAMRAA/DOD W81XWH-10-1-0874), DebRA International, the Jackson Gabriel Silver Fund, the Epidermolysis Bullosa Medical Research Fund, University of Pennsylvania grant MPS I-11-009-01, and Children’s Cancer Research Fund, Minnesota.

Publisher Copyright:
© 2015 Elsevier Inc. All rights reserved..

Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.

Keywords

Blood and marrow transplantation
DNA structure
Eusocial team
Gene editing
Gene therapy
Immunological tolerance
Nuclear transfer
Selfish transgene
Somatic mosaicism
Stem cell therapy

Access

10.1016/B978-0-12-800563-7.00001-4

OpenUrl availability

Full text

Cite this

@inbook{2a3ccc6af21e42c4af8f30ddecf02c54,

title = "Translating Genome Engineering to Survival",

abstract = "An incredible number and diversity of genetic diseases afflict humans. Despite the best efforts of medicine to reduce the suffering these diseases cause, curing them has remained out of reach. We are now at the point in time where genome engineering is stunningly close to being able to repair a genetic error and restore gene function. This volume outlines important examples of the tools and practice of gene therapy today. This incredible capability remains at the edges of existing science in new and predictably controversial territory. Similar to any other medical intervention, gene therapy is not devoid of risks. Understanding and controlling these risks while moving these technologies into the practice of medicine remain the goals for translational research. The chapters you are about to read demonstrate that fluency across basic science and clinical practice is possible and necessary for the robust application of gene therapy to improved survival.",

keywords = "Blood and marrow transplantation, DNA structure, Eusocial team, Gene editing, Gene therapy, Immunological tolerance, Nuclear transfer, Selfish transgene, Somatic mosaicism, Stem cell therapy",

author = "Jakub Tolar",

note = "Funding Information: The author apologizes to the authors whose work could not be quoted because of space constraints and thanks Nancy Griggs Morgan for editorial assistance. J.T. is supported by grants from the National Institutes of Health (R01 AR063070 and R01 AR059947), the Department of Defense (USAMRAA/DOD Department of the Army W81XWH-12-1-0609 and USAMRAA/DOD W81XWH-10-1-0874), DebRA International, the Jackson Gabriel Silver Fund, the Epidermolysis Bullosa Medical Research Fund, University of Pennsylvania grant MPS I-11-009-01, and Children{\textquoteright}s Cancer Research Fund, Minnesota. Publisher Copyright: {\textcopyright} 2015 Elsevier Inc. All rights reserved.. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.",

year = "2015",

doi = "10.1016/B978-0-12-800563-7.00001-4",

language = "English (US)",

isbn = "9780128005637",

pages = "1--10",

booktitle = "Translating Gene Therapy to the Clinic",

publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Translating Genome Engineering to Survival

AU - Tolar, Jakub

N1 - Funding Information: The author apologizes to the authors whose work could not be quoted because of space constraints and thanks Nancy Griggs Morgan for editorial assistance. J.T. is supported by grants from the National Institutes of Health (R01 AR063070 and R01 AR059947), the Department of Defense (USAMRAA/DOD Department of the Army W81XWH-12-1-0609 and USAMRAA/DOD W81XWH-10-1-0874), DebRA International, the Jackson Gabriel Silver Fund, the Epidermolysis Bullosa Medical Research Fund, University of Pennsylvania grant MPS I-11-009-01, and Children’s Cancer Research Fund, Minnesota. Publisher Copyright: © 2015 Elsevier Inc. All rights reserved.. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.

PY - 2015

Y1 - 2015

N2 - An incredible number and diversity of genetic diseases afflict humans. Despite the best efforts of medicine to reduce the suffering these diseases cause, curing them has remained out of reach. We are now at the point in time where genome engineering is stunningly close to being able to repair a genetic error and restore gene function. This volume outlines important examples of the tools and practice of gene therapy today. This incredible capability remains at the edges of existing science in new and predictably controversial territory. Similar to any other medical intervention, gene therapy is not devoid of risks. Understanding and controlling these risks while moving these technologies into the practice of medicine remain the goals for translational research. The chapters you are about to read demonstrate that fluency across basic science and clinical practice is possible and necessary for the robust application of gene therapy to improved survival.

AB - An incredible number and diversity of genetic diseases afflict humans. Despite the best efforts of medicine to reduce the suffering these diseases cause, curing them has remained out of reach. We are now at the point in time where genome engineering is stunningly close to being able to repair a genetic error and restore gene function. This volume outlines important examples of the tools and practice of gene therapy today. This incredible capability remains at the edges of existing science in new and predictably controversial territory. Similar to any other medical intervention, gene therapy is not devoid of risks. Understanding and controlling these risks while moving these technologies into the practice of medicine remain the goals for translational research. The chapters you are about to read demonstrate that fluency across basic science and clinical practice is possible and necessary for the robust application of gene therapy to improved survival.

KW - Blood and marrow transplantation

KW - DNA structure

KW - Eusocial team

KW - Gene editing

KW - Gene therapy

KW - Immunological tolerance

KW - Nuclear transfer

KW - Selfish transgene

KW - Somatic mosaicism

KW - Stem cell therapy

UR - http://www.scopus.com/inward/record.url?scp=84944402092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944402092&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-800563-7.00001-4

DO - 10.1016/B978-0-12-800563-7.00001-4

M3 - Chapter

AN - SCOPUS:84944402092

SN - 9780128005637

SP - 1

EP - 10

BT - Translating Gene Therapy to the Clinic

PB - Elsevier Inc.

ER -

Translating Genome Engineering to Survival

Abstract

Bibliographical note

Keywords

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this